相似文献
1
Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors.
J Virol. 2008 Mar;82(6):3125-30. doi: 10.1128/JVI.01533-07. Epub 2007 Dec 12.
2
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
3
[Antiviral defense by APOBEC3 family proteins].
Uirusu. 2005 Dec;55(2):267-72. doi: 10.2222/jsv.55.267.
4
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Clin Microbiol Infect. 2016 Feb;22(2):191-200. doi: 10.1016/j.cmi.2015.10.004. Epub 2015 Oct 23.
5
Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals.
J Int AIDS Soc. 2013 Feb 25;16(1):18472. doi: 10.7448/IAS.16.1.18472.
6
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
PLoS Pathog. 2014 Jul 31;10(7):e1004281. doi: 10.1371/journal.ppat.1004281. eCollection 2014 Jul.
7
Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
Arch Virol. 2009;154(10):1579-88. doi: 10.1007/s00705-009-0481-y. Epub 2009 Aug 12.
8
APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
J Virol. 2006 Feb;80(4):2069-72. doi: 10.1128/JVI.80.4.2069-2072.2006.
9
Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya.
J Virol. 2008 Aug;82(16):8172-82. doi: 10.1128/JVI.01115-08. Epub 2008 Jun 11.
10
An Alu Element Insertion in Intron 1 Results in Aberrant Alternative Splicing of APOBEC3G Pre-mRNA in Northern Pig-Tailed Macaques () That May Reduce APOBEC3G-Mediated Hypermutation Pressure on HIV-1.
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01722-19.
引用本文的文献
1
From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir.
J Transl Med. 2025 Aug 13;23(1):906. doi: 10.1186/s12967-025-06919-z.
2
Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.
J Mol Biol. 2022 Jan 30;434(2):167355. doi: 10.1016/j.jmb.2021.167355. Epub 2021 Nov 10.
3
HIV replication and latency in monocytes and macrophages.
Semin Immunol. 2021 Jan;51:101472. doi: 10.1016/j.smim.2021.101472. Epub 2021 Feb 27.
4
Deficient uracil base excision repair leads to persistent dUMP in HIV proviruses during infection of monocytes and macrophages.
PLoS One. 2020 Jul 14;15(7):e0235012. doi: 10.1371/journal.pone.0235012. eCollection 2020.
5
Impact of Suboptimal APOBEC3G Neutralization on the Emergence of HIV Drug Resistance in Humanized Mice.
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.01543-19.
6
An Alu Element Insertion in Intron 1 Results in Aberrant Alternative Splicing of APOBEC3G Pre-mRNA in Northern Pig-Tailed Macaques () That May Reduce APOBEC3G-Mediated Hypermutation Pressure on HIV-1.
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01722-19.
7
expression and HIV-1 infection in Burkina Faso.
J Public Health Afr. 2018 Dec 21;9(3):907. doi: 10.4081/jphia.2018.907.
8
APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
Front Immunol. 2018 Aug 8;9:1839. doi: 10.3389/fimmu.2018.01839. eCollection 2018.
9
Diversity of Immunoglobulin (Ig) Isotypes and the Role of Activation-Induced Cytidine Deaminase (AID) in Fish.
Mol Biotechnol. 2018 Jun;60(6):435-453. doi: 10.1007/s12033-018-0081-8.
10
APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms.
Front Microbiol. 2016 Dec 19;7:2027. doi: 10.3389/fmicb.2016.02027. eCollection 2016.
本文引用的文献
1
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
J Virol. 2007 Aug;81(15):8201-10. doi: 10.1128/JVI.00395-07. Epub 2007 May 23.
2
APOBEC3G levels predict rates of progression to AIDS.
Retrovirology. 2007 Mar 20;4:20. doi: 10.1186/1742-4690-4-20.
3
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.
J Virol. 2007 Mar;81(5):2508-18. doi: 10.1128/JVI.02165-06. Epub 2006 Dec 6.
4
Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
FASEB J. 2007 Jan;21(1):217-22. doi: 10.1096/fj.06-6773com. Epub 2006 Nov 29.
5
Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.
J Biol Chem. 2007 Feb 9;282(6):3539-46. doi: 10.1074/jbc.M610138200. Epub 2006 Nov 16.
6
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15588-93. doi: 10.1073/pnas.0604524103. Epub 2006 Oct 9.
7
Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication.
Nucleic Acids Res. 2006;34(17):4677-84. doi: 10.1093/nar/gkl555. Epub 2006 Sep 8.
8
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
J Virol. 2006 Sep;80(17):8450-8. doi: 10.1128/JVI.00839-06.
9
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
J Exp Med. 2006 May 15;203(5):1357-69. doi: 10.1084/jem.20052319. Epub 2006 May 8.
10
Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
Trends Immunol. 2006 Jun;27(6):291-7. doi: 10.1016/j.it.2006.04.003. Epub 2006 May 4.
Zotero 插件